Oral antioxidants supplementation for women with unexplained infertility undergoing ICSI/IVF: Randomized controlled trial

Autor: Mohamed A. Youssef, Hazem A. Elashmwi, Nevin Elghamary, Dalia Youssef, Ayman N. Raslan, Mohamed N Mohesen, Nadin A. Sherif, Hatem I. Abdelmoty, Aboulfoutouh I. Ismail, Rana Abdella, Ahmed Magdy, Mostafa Abdel Bar, Ahmed S. Ali, Esaad M. Abduljawad, Hisham M. Gouda
Přispěvatelé: Other departments
Rok vydání: 2014
Předmět:
Zdroj: Human fertility (Cambridge, England), 18(1), 38-42. Taylor and Francis Ltd.
ISSN: 1742-8149
1464-7273
Popis: Objective: Good oocyte quality and maturity are important prerequisites for high fertilization and implantation rates in IVF/ ICSI treatment cycles. Reactive oxygen species (ROS) are produced within ovarian follicles, especially during the ovulation process, and increased ROS activity may be a cause of impaired oocyte maturation and higher rate of failure of IVF/ ICSI cycles. Study design: RCT evaluating the effect of antioxidant supplementation on ICSI/IVF outcomes. Two hundred and eighteen women with unexplained subfertility undergoing IVF/ICSI were randomized into two groups. The study group ( n 112) received daily oral antioxidants in the form of multivitamins and minerals (amino acid chelated) while the control group ( n 106) did not. Main outcomes were number of mature metaphase II (MII) oocytes and clinical pregnancy rate. Results: There were no signifi cant changes between the groups as regards age, BMI, basal FSH, number of mature (MII) oocytes (12.7 9.4 vs. 13.2 8.6, P 0.7) and clinical pregnancy rate per woman randomized (38% vs. 34%; [OR 1.2; 95% CI, 0.70 – 2.11]. Conclusion: Oral antioxidants in the form of a combination of multivitamins and minerals (amino acid chelated) did not improve oocyte quality and pregnancy rates in women with unexplained infertility undergoing IVF/ICSI treatment.
Databáze: OpenAIRE